Hoffmann-La Roche: all 2,744 studies
Page 22 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous LeukemiaCompletedNCT01641250Phase 1
- A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected PatientsCompletedNCT01638650Phase 1
- A Study of A High Concentration Liquid Formulation Versus A Lyophilized Formulation of Gantenerumab in Healthy VolunteersCompletedNCT01636531Phase 1
- A Study of Bitopertin (RO4917838) in Healthy Male VolunteersCompletedNCT01636492Phase 1
- A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous LeukemiaCompletedNCT01635296Phase 1
- An Non-Interventional Study of Patients With Persistent Symptoms of SchizophreniaCompletedNCT01634542
- A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT01633970Phase 1
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent GlioblastomaCompletedNCT01632228Phase 2
- A Single Dose Study of Radiolabeled RO4602522 in Healthy VolunteersCompletedNCT01631422Phase 1
- A Study of the Effect of Carbamazepine on the Pharmacokinetics of RO4917523 in Healthy VolunteersCompletedNCT01629368Phase 1
- ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based TreatmentCompletedNCT01628094Phase 2
- A Study of The Effects of Multiple Doses of Ketoconazole on Single Dose Pharmacokinetics of RO4602522 in Healthy Male VolunteersCompletedNCT01625806Phase 1
- A Single-Ascending-Dose Study of RO5469754 in Healthy VolunteersCompletedNCT01620931Phase 1
- Hemophilia B Gene Therapy With AAV8 VectorTerminatedNCT01620801Phase 1
- An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second RelapseCompletedNCT01618747
- An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis PatientsCompletedNCT01615419
- A Study to Compare the Bioavailability of Copegus and Vilona® in Healthy VolunteersCompletedNCT01615393Phase 1
- A Study of Aleglitazar in Combination With Oral Contraceptive Healthy VolunteersCompletedNCT01615354Phase 1
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)CompletedNCT01615068
- A Study of the Effect of RO4917838 on the QTcF Interval in Healthy VolunteersCompletedNCT01613040Phase 1
- A Relative Bioavailability Study of Setrobuvir Tablet Formulation Versus Reference Setrobuvir Capsule Formulation in Healthy VolunteersCompletedNCT01612143Phase 1
- A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart DiseaseCompletedNCT01609140Phase 2
- An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE)CompletedNCT01609075
- An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver CirrhosisCompletedNCT01609049
- An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular LymphomaTerminatedNCT01609036
- A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue SarcomaCompletedNCT01605526Phase 1
- An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)TerminatedNCT01604252
- An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)CompletedNCT01598597
- A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male VolunteersCompletedNCT01592890Phase 1
- A Pharmacodynamic and Pharmacokinetic Study of RO5508887 in Healthy VolunteersCompletedNCT01592331Phase 1
- A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy VolunteersCompletedNCT01592318Phase 1
- A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or AtazanavirCompletedNCT01592305Phase 1
- A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy VolunteersCompletedNCT01591850Phase 1
- A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal CancerCompletedNCT01590719Phase 2
- A Study of Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir in Healthy VolunteersCompletedNCT01588002Phase 1
- A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)CompletedNCT01582503Phase 2
- A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down SyndromeCompletedNCT01580384
- A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor TreatmentWithdrawnNCT01579019Phase 2
- A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And NeckCompletedNCT01577173Phase 2
- An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)CompletedNCT01565122
- An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Treated With GlucocorticoidsCompletedNCT01564901
- A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or LymphomaCompletedNCT01564251Phase 1
- A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade GliomaCompletedNCT01547546Phase 1
- A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)CompletedNCT01545453Phase 2
- A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)CompletedNCT01545440Phase 2
- A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy VolunteersCompletedNCT01543529Phase 1
- A Study of MCAF5352A in Healthy VolunteersCompletedNCT01540760Phase 1
- A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy VolunteersCompletedNCT01531647Phase 1
- A Study of DEDN6526A in Patients With Metastatic or Unresectable MelanomaCompletedNCT01522664Phase 1
- A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung CancerCompletedNCT01519804Phase 2
- A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy VolunteersCompletedNCT01519336Phase 1
- A Study of RO4917523 in Patients With Fragile X SyndromeCompletedNCT01517698Phase 2
- A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular DiseaseCompletedNCT01516541Phase 3
- Study of RO6807952 in Patients With Diabetes Mellitus Type 2TerminatedNCT01516476Phase 2
- A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy VolunteersCompletedNCT01514968Phase 1
- A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic FunctionCompletedNCT01513083Phase 1
- An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)CompletedNCT01512420
- Non-invasive Chromosomal Examination of Trisomy StudyCompletedNCT01511458
- A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838CompletedNCT01510899Phase 1
- A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular CarcinomaCompletedNCT01507168Phase 2
- An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)CompletedNCT01506167
- A Study of RG7667 in Healthy VolunteersCompletedNCT01496755Phase 1
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung CancerCompletedNCT01496742Phase 2
- A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy VolunteersCompletedNCT01495104Phase 1
- A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid TumorsCompletedNCT01494688Phase 1
- Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung CancerCompletedNCT01493843Phase 2
- A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid TumoursCompletedNCT01493336Phase 1
- A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle GlaucomaCompletedNCT01493271Phase 2
- An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung CancerCompletedNCT01488331
- An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic LeukemiaCompletedNCT01488162
- Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female SubjectsCompletedNCT01487239Phase 1
- An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in KenyaCompletedNCT01484483
- A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated CirrhosisCompletedNCT01483742Phase 2
- A Relative Bioavailability Study of Danoprevir and Ritonavir in Healthy VolunteersCompletedNCT01483729Phase 1
- A Human Proof of Concept Study for [11C]-RO5011232 as Radiotracer and Study of the Binding of RO4917523 to Human mGlu5 Brain Receptor at Steady-State in Healthy VolunteersCompletedNCT01483469Phase 1
- An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)CompletedNCT01483326
- A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis CCompletedNCT01482403Phase 2
- A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis CCompletedNCT01482390Phase 2
- A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell OriginCompletedNCT01482377Phase 1
- Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy VolunteersCompletedNCT01480310Phase 1
- Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0941 Following Single Oral Dose Administration in Healthy Male SubjectsCompletedNCT01474668Phase 1
- A Study of RO5028442 in Adult Male High-Functioning Autistic PatientsCompletedNCT01474278Phase 1
- Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980CompletedNCT01473316Phase 1
- A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian CancerCompletedNCT01469793Phase 1
- A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except LeukemiaCompletedNCT01462175Phase 1
- A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy VolunteersCompletedNCT01461967Phase 1
- Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT01461317Phase 2
- ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant TreatmentCompletedNCT01457677Phase 2
- A Study of RO4995819 in Healthy Elderly VolunteersCompletedNCT01457664Phase 1
- A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)CompletedNCT01456325Phase 3
- A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNCT01455701Phase 1
- A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial CarcinomaCompletedNCT01455493Phase 2
- Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted TherapyCompletedNCT01442090Phase 2
- A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug UsersCompletedNCT01438749Phase 1
- MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant TherapyCompletedNCT01437657Phase 2
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor TherapyCompletedNCT01437566Phase 2
- A Study of RG1662 in Individuals With Down SyndromeCompletedNCT01436955Phase 1
- A Pharmacokinetic Study of RO4917838 in Healthy Chinese VolunteersCompletedNCT01433575Phase 1
- A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01432353Phase 1
- A Study of Navitoclax in Addition to Bendamustine and Rituximab in Patients With Relapsed Diffuse Large B-Cell Lymphoma (NAVIGATE)WithdrawnNCT01423539Phase 2